Peter Attia MD#140 - Gerald Shulman, MD, PhD: Insulin resistance—molecular mechanisms and clinical implications
At a glance
WHAT IT’S REALLY ABOUT
Gerald Shulman Explains Insulin Resistance From Muscle Lipids to Liver
- Shulman describes using NMR spectroscopy to measure metabolic flux inside living human cells, showing that muscle insulin resistance stems from a block in glucose transport caused by diacylglycerol activating novel PKC isoforms.
- He lays out a progression in humans from muscle insulin resistance to hyperinsulinemia, increased liver de novo lipogenesis, fatty liver, hepatic insulin resistance and ultimately fasting hyperglycemia driven by accelerated gluconeogenesis.
- Exercise can bypass the muscle transport block, likely via AMPK-driven GLUT4 translocation, and a single bout reduced liver fat synthesis in insulin-resistant young people.
- Shulman proposes insulin resistance is an evolutionarily conserved protection during starvation that preserves glucose for the brain, but becomes harmful in an overnutrition environment.
- On treatment, he favors a liver-targeted mitochondrial uncoupler to burn liver fat safely, and argues metformin works through a redox mechanism at glycerol-3-phosphate dehydrogenase rather than complex I, leaving its use for longevity an open question.
IDEAS WORTH REMEMBERING
5 ideasFlux, not static concentration, reveals metabolic disease
Shulman says blood tests give only a snapshot, whereas NMR with isotope labeling lets researchers track glucose into glycogen and see where biochemical roadblocks occur inside human muscle and liver.
The muscle defect in insulin resistance is at glucose transport
Measuring both glucose-6-phosphate and intracellular glucose as reduced pointed to transport rather than hexokinase or glycogen synthase, even in lean young insulin-resistant volunteers.
Diacylglycerol, not triglyceride, is the culprit
Triglycerides are an inert storage form and merely a marker, while DAGs activate PKC theta and epsilon to block insulin signaling; knockout and overexpression studies in animals supported this.
Muscle insulin resistance may drive fatty liver in humans
In young insulin-resistant volunteers, ingested carbohydrate that can't enter muscle glycogen is diverted to liver fat synthesis amid portal hyperinsulinemia, raising triglycerides and lowering HDL before glucose becomes abnormal.
Gluconeogenesis is regulated largely indirectly via fat cells and acetyl-CoA
Shulman argues insulin suppresses gluconeogenesis mostly by braking peripheral lipolysis, lowering acetyl-CoA and glycerol delivery, while inflammation-driven lipolysis pushes diabetics into fasting hyperglycemia.
WORDS WORTH SAVING
5 quotesIf we're gonna be serious about the business of delaying the onset of death, we have to be serious about the business of delaying the onset of chronic disease. And if we want to do that, we must fix our metabolisms.
— Peter Attia
Biochemistry is the same thing. You have a roadblock, and traffic builds up behind it.
— Dr. Gerald Shulman
In my view, insulin resistance was a protective mechanism throughout evolution that allowed us to survive all species during starvation, which was probably the predominant environmental exposure we've had for the last many, many millennia.
— Dr. Gerald Shulman
If I had to pick two molecules that are driving metabolic disease, it's acetyl-CoA driving pyruvate carboxylase and again, the diacylglycerols activating epsilon.
— Dr. Gerald Shulman
Triglycerides are neutral, so I want to emphasize this. So even though triglycerides often track with insulin resistance, we've dissociated it inside the muscle cell and liver cell from insulin resistance.
— Dr. Gerald Shulman
High quality AI-generated summary created from speaker-labeled transcript.
